What is the price benchmark to replace Average Wholesale Price (AWP)?

Journal of Managed Care Pharmacy

Volumn 16, Issue 7, 2010, Pages 492-501

  Curtiss, Frederic R ^b   Lettrich, Phillip ^a   Fairman, Kathleen A ^b  

^a Emdeon   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG; DRUG;

DATA BASE; DRUG COST; DRUG MANUFACTURE; DRUG MARKETING; HEALTH INSURANCE; PHARMACY; REIMBURSEMENT; REVIEW; ECONOMICS; HUMAN; QUALITY CONTROL; UNITED STATES;

BENCHMARKING; DRUG COSTS; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; PHARMACEUTICAL PREPARATIONS; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 77958528027     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2010.16.7.492     Document Type: Review

References (48)

1. Martinez B. How quiet moves by a publisher sway billions in drug spending. Wall Street J. October 6, 2006:A1, A12. Available at: http://www.dc37.net/news/newsreleases/2006/drugpricing-WallStJ.pdf. Accessed July 26, 2010.
2. Department of Health and Human Services, Office of Inspector General. Medicaid pharmacy - actual acquisition cost of prescription drug products for brand name drugs. OIG report no. A-06-96-00030. April 1997. Available at: http://oig.hhs.gov/oas/reports/region6/69600030.pdf. Accessed July 27, 2010.
3. Department of Health and Human Services, Office of Inspector General. Excessive Medicare payments for prescription drugs. OIG report no. OEI- 03-97-00290. December 1997. Available at: http://oig.hhs.gov/oei/reports/oei-03- 97-00290.pdf. Accessed July 26, 2010.
4. AMCP guide to pharmaceutical payment methods, 2009 update (version 2.0). J Manag Care Pharm. 2009;15(6-a):S1-S61. Available at: http://www.amcp.org/data/ jmcp/1002.pdf.
5. U.S. District Court, District of Massachusetts. Case 1:05-cv-11148-PBS. Document 720. Filed March 17, 2009. New England Carpenters Health Benefits Fund, et al., v. First DataBank, Inc. and McKesson Corporation, civil action no. 05-11148-PBS, and
6. District Council 37 Health and Security Plan v. Medi-Span, a division of Wolters Kluwer Health Inc., civil action no. 07-10988-PBS. Available at: http://www.firstdatabank.com/download/pdf/ OrderGrantingFinalApprovalofSettlement031709.pdf. Accessed July 27, 2010.
7. U.S. District Court, District of Massachusetts. Case 1:05-cv-11148-PBS. Document 722. Filed March 30, 2009. New England Carpenters Health Benefits Fund, et al., v. First DataBank, Inc. and McKesson Corporation, civil action no. 05-11148-PBS, and
8. District Council 37 Health and Security Plan v. Medi-Span, a division of Wolters Kluwer Health Inc., civil action no. 07-10988-PBS. Available at: http://www.firstdatabank.com/download/pdf/FinalJudgment.pdf. Accessed July 26, 2010.
9. Preliminary Blue Book AWP adjustment report - overview. August 2009. First DataBank, San Francisco, CA.
10. First Databank. AWP communications. Update regarding AWP litigation - final order and judgement entered. March 31, 2009. Available at: http://www.firstdatabank.com/Support/awp-communications.aspx. Accessed July 26, 2010.
11. Wolters Kluwer Health. Customer letter. April 1, 2009. Available at: http://www.medispan.com/Common/PDF/CustomerLetter-April12009-FINAL.pdf. Accessed July 26, 2010.
12. Thomson Reuters. Red Book from Thomson Reuters continues providing average wholesale prices for drugs as others stop supplying this important data. April 8, 2010. Available at: http://thomsonreuters.com/content/press-room/tsh/ red-book-continues-providing-wholesale-prices. Accessed July 26, 2010.
13. Media releases. Gold Standard/Elsevier offers timely, transparent, reliable drug pricing data, including average wholesale price (AWP). May 18, 2010. Available at: http://www.goldstandard.com/pages/ViewRelease.aspx?id=138. Accessed July 26, 2010.
14. Wolters Kluwer Health. Pricing policy update. Important notice for Wolters Kluwer Health's Medi-Span customers. Available at: http://www.medispan. com/Pricing-Policy-Update.aspx. Accessed July 26, 2010.
15. Swanson B. The impact of AWP litigation on your PBM contract. Milliman Health Perspectives. August 2009. Available at: http://publications.milliman. com/periodicals/health-perspectives/pdfs/health-perspectivesaugust-2009.pdf. Accessed July 26, 2010.
16. WellPoint nextRx. Average wholesale pricing. Frequently asked questions. Available at: https://www.wellpointnextrx.com/shared/noapplication/f0/s0/t0/pw- b135238.pdf. Accessed July 26, 2010.
17. State of Tennessee. Bureau of Tenncare. Department of Finance and Administration. Average wholesale price (AWP) litigation settlement and impact on pharmacy reimbursement. September 18, 2009. Available at: https://tnm.providerportal.sxc.com/rxclaim/TNM/AWP%20Change%20Memo%20091809.pdf. Accessed July 26, 2010.
18. American Medicaid Pharmacy Administrators Association and the National Association of State Medicaid Directors. Executive summary and white paper. Post AWP pharmacy pricing and reimbursement. November 2009. Revision dated June 2010 available at: http://www.nasmd.org/home/doc/SummaryofWhitePaper.pdf. Accessed July 27, 2010.
19. Social Security Act. Section 1847A. Use of average sales price payment methodology. 42 U.S.C. § 1395w-3a, Section 303(c)6(B). Social Security Online. Compilation of Social Security laws. Available at: http://www.ssa.gov/ OP-Home/ssact/title18/1847A.htm. Accessed July 26, 2010.
20. National Council of Prescription Drug Programs. NCPDP's quarterly technical work group meetings. April 5, 2010. Available at: http://ncpdp.org/ members/pdf/May2010WGNotification.pdf. Accessed July 26, 2010.
21. Alabama Medicaid Agency. Pharmacy services. AAC program implementation. Available at: http://www.medicaid.alabama.gov/programs/pharmacy-svcs/AAC.aspx. Accessed July 27, 2010.
22. Myers and Stauffer. Alabama State MAC list. Available at: http://al.mslc.com/MacList.aspx. Accessed August 8, 2010.
23. U.S. Federal Business Opportunities. Survey of retail prices, payment and utilization rates, and performance rankings. Solicitation number RFP-CMS-2010-0047. July 16, 2010. Available at: https://www.fbo.gov/index?s= opportunity&mode=form&id=45cd27a2e44e2b084e95bef234c49acf&tab= core&-cview=1. Accessed July 27, 2010.
24. Social Security Act. Section 1927. Payment for covered outpatient drugs. Requirement for rebate agreement. Social Security Online. Compilation of Social Security laws. Available at: http://www.socialsecurity.gov/OP-Home/ssact/ title19/1927.htm. Accessed July 26, 2010.
25. Department of Health and Human Services, Office of Inspector General. Medicaid drug price comparisons: average manufacturer price to published prices. Report no. OEI-05-05-00240. June 2005. Available at: http://oig.hhs.gov/oei/ reports/oei-05-05-00240.pdf. Accessed July 26, 2010.
26. Department of Health and Human Services, Office of Inspector General. Determining average manufacturer prices for prescription drugs under the Deficit Reduction Act of 2005. Report no. A-06-06-00063. May 30, 2006. Available at: http://oig.hhs.gov/oas/reports/region6/60600063.pdf. Accessed July 26, 2010.
27. Arnold & Porter, LLP. Client Advisory. CMS issues final rule implementing Medicaid provisions of Deficit Reduction Act. July 2007. Available at: http://www.arnoldporter.com/resources/documents/A&PCA- CMSIssuesFinalRuleImplementingMedicaidProvisionsofDeficitReductionAct-07092007. pdf. Accessed July 27, 2010.
28. Medicare Improvements for Patients and Providers Act of 2008 (Public Law 110-275). July 15, 2008. Available at: http://frwebgate.access.gpo.gov/cgi-bin/ getdoc.cgi?dbname=110-cong-public-laws&docid=f:publ275.110.pdf. Accessed July 27, 2010.
29. Centers for Medicare & Medicaid Services. Policy and reimbursement. Spotlight - Medicaid prescription drugs under the Affordable Care Act. Available at: https://www.cms.gov/Reimbursement/02-Spotlight.asp. Accessed June 6, 2010.
30. Centers for Medicare & Medicaid Services. Medicaid drug pricing regulation: a summary. July 6, 2007. Available at: http://www.cms.gov/apps/ media/press/factsheet.asp?Counter=2255&intNumPerPage=10&checkDate= &checkKey=&srchType=1&numDays=3500&srchOpt=0&srchData= &keywordType=All&chkNewsType=6&intPage=&showAll=&pYear= &year=&desc=false&cboOrder=date. Accessed July 26, 2010.
31. Department of Health and Human Services, Office of Inspector General. Memorandum report: Comparison of first-quarter 2008 average sales prices and average manufacturer prices: impact on Medicare reimbursement for third quarter 2008. Report no. OEI-03-08-00530. December 23, 2008. Available at: www.oig.hhs.gov/oei/reports/oei-03-08-00530.pdf. Accessed July 26, 2010.
32. Medicare Program: Changes to the hospital outpatient prospective payment system and CY 2009 payment rates. Federal Register. November 18, 2008;73(223). Available at: http://edocket.access.gpo.gov/2008/E8-26212.htm. Accessed July 27, 2010.
33. U.S. Food and Drug Administration. National drug code directory. August 2, 2010. Available at: http://www.fda.gov/Drugs/InformationOnDrugs/ucm142438. htm. Accessed August 8, 2010.
34. Koon ML. AWP through the looking glass: Industrywide litigation by definition. For The Defense. October 2005. Available at: http://el.shb.com/nl- images/SHBWebsite/PracticeAreas/Pharma/Pubs/IndustrywideLitigation-2005.pdf. Accessed July 26, 2010.
35. In Re Pharmaceutical Industry Average Wholesale Price Litigation. Re: Trial of Class 2 and Class 3 claims. U.S. District Court, District of Massachusetts. M.D.L. no. 1456, civil action no. 01-12257-PBS, document 4366. Filed June 21, 2007. Available at: http://www.prescriptionaccess.org/docs/AWP-6- 21-07-Order.pdf. Accessed July 26, 2010.
36. Rubinstein E, Curtiss FR. How much "spread" in AWP pricing is unlawful? J Manag Care Pharm. 2007;13(6):515-16. Available at: http://www.amcp.org/data/jmcp/pages%20515-16.pdf.
37. U.S. Code of Federal Regulations. Title 42, Volume 4. 42CFR447.512. Drugs: aggregate upper limits of payment. October 1, 2007. Available at: http://edocket.access.gpo.gov/cfr-2007/octqtr/42cfr447.512.htm. Accessed July 26, 2010.
38. U.S. Code of Federal Regulations. Title 42, Volume 4. 42CFR447.301. Definitions. Available at: http://edocket.access.gpo.gov/cfr-2006/octqtr/ 42cfr447.301.htm. Accessed July 26, 2010.
39. Centers for Medicaid & Medicaid Services. Medicaid policy and reimbursement. Overview - Medicaid prescription reimbursement information by state - quarter ending March 2010. April 1, 2010. Available at: https://www.cms.gov/Reimbursement/Downloads/reimbursementchart1q2010.pdf. Accessed July 26, 2010.
40. U.S. Government Accountability Office. Medicaid outpatient prescription drugs: estimated 2007 federal upper limits for reimbursement compared with retail pharmacy acquisition costs. Medicaid federal upper limits. Report no. GAO-07-239R. December 22, 2006. Available at: http://www.gao.gov/new.items/ d07239r.pdf. Accessed July 26, 2010.
41. Department of Health and Human Services, Office of Inspector General. State's use of new drug pricing data in the Medicaid program. Report no. OEI-03-06-00490. April 2007. Available at: http://oig.hhs.gov/oei/reports/oei- 03-06-00490.pdf. Accessed July 26, 2010.
42. Centers for Medicare & Medicaid Services. Policy and reimbursement. Federal upper limits. March 18, 2010. Available at: https://www.cms.gov/ Reimbursement/05-FederalUpperLimits.asp#TopOfPage. Accessed July 27, 2010.
43. Department of Health and Human Services, Office of Inspector General. Variation in state Medicaid drug prices. Report no. OEI-05-02-00681. September 2004. Available at: http://oig.hhs.gov/oei/reports/oei-05-02-00681.pdf. Accessed June 7, 2010.
44. Wolters Kluwer Health. Wolters Kluwer Health average wholesale price (AWP) policy. Effective June 21, 2010. Available at: http://www.medispan.com/ common/pdf/wkh-AWP-policy.pdf. Accessed July 26, 2010.
45. Alabama Medicaid Agency. AAC drug pricing, dispense fee increase pending before CMS. May 28, 2010. Available at: http://www.medicaid.alabama.gov/ documents/News/MM-Articles/MM-AAC-COD-Update-5-28-10-FINAL.pdf. Accessed July 26, 2010.
46. Associated Press. Jury orders AstraZeneca to pay damages in suit. Wall Street J. Feb 22, 2008:B6.
47. Stevenson KL. Litigation news. Alabama Supreme Court overturns fraud verdicts against drug companies. American Bar Association. February 22, 2010. Available at: http://www.abanet.org/litigation/litigationnews/top-stories/ 022210-astrazeneca-alabama-supreme-court-pharmaceutical-prices.html. Accessed July 26, 2010.
48. Supreme Court of Alabama. October Term, 2009-1010. AstraZeneca LP and AstraZeneca Pharmaceuticals LP v. State of Alabama; Smithkline Beecham Corporation v. State of Alabama; Novartis Pharmaceuticals Corporation v. State of Alabama. October 16, 2009. Available at: http://www.alabamaappellatewatch. com/uploads/file/1071439.PDF. Accessed July 26, 2010.